Product Acquisition Opportunity:
Xeglyze®

COMPELLING PRODUCT ATTRIBUTES
ABOUT HEAD LICE
There are approximately 100m+ infestations globally each year with substantial social cost. In the USA alone, there are 6‐12m cases annually with more than 7m treatments annually.
Recently, resistance to current products containing permethrin, malathion & pyrethrin has been increasing, and treatment failure drives patients to seek physician advice.
EXISTING TREATMENTS FAIL
The existing products on the market are only effective against lice only and not eggs, and most products require repeat treatments to break life cycle of a head lice infestation, leading to poor compliance which adversely affects efficacy.
© Hatchtech Pty Ltd. All Rights Reserved.